Leo Pharma Wins FDA Nod for Skin Cancer Gel - Jan. 25, 2012

Having trouble viewing this email? View in Browser.

Wednesday, January 25, 2012  |   |   |   |  Partnerships 2012: The Largest Yet Most Intimate Gathering of Clinical Decision Makers in the World The world has radically changed in just the last few years and the trend is likely to continue at an exponential rate. Partnerships in Clinical Trials is changing with it. Partnerships has always been where business gets done and strategic partnership deals are inked, but in 2012 it is where the industry moves forward with answers. We've taken your most pressing challenges and translated them into the most provocative meeting agenda the industry has ever seen. For more information, please visit the conference site: http://www.iirusa.com/cropartners/welcome-to-CROs.xml?registration=XP1700BSENL. •  LEO Pharma Wins FDA Nod for Skin Cancer Gel More... •  UCB, Inc. (UCBJF.PK) Announces FDA Approval for Keppra® in Infants and Children from One Month of Age with Partial Onset Seizures More... More Drug Approval News •  Cancer Patient Success Prompts Cannabis Science Inc. to Begin FDA Investigational New Drug (IND) Application Process More... More BLA/NDA/ANDA News More IND News More MAA News •  Gilead Sciences, Inc. (GILD) Initiates Phase 2 Clinical Trial Evaluating GS-7340, A Low-Dose Novel Prodrug of Tenofovir for the Treatment of HIV More... •  Depomed, Inc. (DEPO) Announces Initiation of Phase 2 Clinical Study in Parkinson's Disease More... •  Kaiser Permanente Study Finds Gardasil Does Not Trigger Lupus, Rheumatoid Arthritis or Type 1 Diabetes After Vaccination More... •  Amorcyte Inc., a NeoStem, Inc. Company, Enrolls First Patient in PreSERVE Phase 2 Trial for Acute Myocardial Infarction More... •  Chimerix, Inc. Announces Presentation of Final Data from CMX001 Phase 2 Trial in Prophylaxis of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients More... More Phase III News More Phase II News More Phase I News More Pre-Clinical News More Post-Approval News Quantifying the Value of Pipeline Pilot, the Accelrys Scientific Enterprise Platform This white paper outlines the methodology, sources of value, and quantifiable results from bringing products to market faster, avoiding unproductive experiments, saving developer time, and more. Request Now! •  Expose to Common Chemicals Reduce Effectiveness of Vaccines in Kids, Harvard School of Public Health Study More... •  Frying With Olive, Sunflower Oil OK for Heart, Autonomous University of Madrid Study More... •  Pycnogenol (French Maritime Pine Bark Extract) Shown to Improve Visible Signs of Aging in New Study, Leibniz Research Institute Study More... •  Brown Fat Burns Calories in Adult Humans, Universite de Sherbrooke Study More... •  University of California, Los Angeles (UCLA) Study Shows How Stress Triggers Immune System More... More General Clinical Research News SafeBridge Consultants, Inc. announces two Potent Compound Safety Training offerings (may be taken separately or consecutively) The SafeBridge original Potent Compound Safety "Boot Camp"® (Boot Camp I) is a comprehensive two-day course in pharmaceutical potent compound safety focused on training EH&S and related professionals in critical technical concepts and proactive safety programs in pharmaceutical industrial hygiene, occupational and environmental toxicology, analytical chemistry, and risk communication. The SafeBridge Advanced Concepts to Support Drug Development of Potent Compounds from R&D through Manufacturing (Boot Camp II) is a one-day advanced course focused on case studies and problem-solving to address potent compound safety issues in discovery, development, contract manufacturing and commercialization. COURSE SEATING IS LIMITED AND USUALLY SELLS OUT! San Diego, CA Boot Camp I May 15-16, 2012 Boot Camp II May 17, 2012 Contact: Susan Custer: susan.custer@safebridge.com or 650-961-4820 x 231 or www.safebridge.com. New Emerging R&D and Clinical Trial Locations • Compare 5 new emerging R&D locations in terms of population, economic activity, healthcare infrastructure, and current R&D activity. • Analyze how clinical trial numbers are changing in China, India, and Eastern Europe. • Develop strategies for geographic outsourcing. Click Here for More Information. • BioMidwest (Deerfield, Illinois) Baxter International, Inc. Project Leader, Clinical and Scientific Affairs Supports clinical trials utilizing stem cells in therapeutic areas of regenerative medicine. Specifically, the individual will support the manufacture of the biological components of the Isolex system used for the selection of CD34+ stem cells from mobilized apheresis products. • Biotech Beach (San Diego, California) Nexus Dx Clinical Research Associate Will initiate activities related to the conduct of clinical studies, oversee those activities during the study including adherence to Good Clinical Practices (GCPs). Represents Company in the research community and develops collaborative relationships with investigative sites and contract research organizations. • Pharm Country (New York, New York) Roche Diagnostics Clinical Specialist Will support all aspects of clinically focused sales for Roche's ACCU-CHEK product line, which includes blood glucose meters, insulin delivery systems, diabetes information management solutions, diabetes programs and services, and co-promoted product solutions within an assigned territory. • Rocky Bio (Phoenix, Arizona) Verinata Health, Inc. Clinical Account Manager Responsible for growing market share for the Verinata prenatal test. This individual will focus on the implementation of sales strategy, achievement of financial milestones and introduction of new clinical technology within the defined territory. • Biotech Bay (San Francisco, California) Sprim Clinical Trial Manager Will manage multiple studies and sites, working with US sponsors, US sites, and international Sprim offices. Will require taking on a broad range of responsibilities from basic project administration to clinical trial leadership. • Get Noticed! Add your resume to the BioSpace Career Center! • See more than 5,000 job postings in the BioSpace Career Center! Genetown Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Northeast region. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Genetown Career Fair, Cambridge, MA February 21, 2012 • BioSpace Career Fair at CALBIO2012, San Francisco, CA March 7, 2012 • BioMidwest Career Fair, Bridgewater, NJ March 22, 2012 • Biotech Beach Career Fair, La Jolla, CA April 17, 2012 • BioCapital Career Fair, Bethesda, MD April 25, 2012 • Pharm Country Career Fair, King Of Prussia, PA May 1, 2012 • BioNC Career Fair, Durham, NC May 2, 2012 • Biotech Bay Career Fair, Burlingame, CA May 29, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services •  Macoven Pharmaceuticals, LLC Named in Suit for Patent Violation and Lanham Act Violation More... •  Affectis Pharmaceuticals AG Granted Patent for AFC-5128, Other P2X7 Antagonists More... More Patent News •  National Institute for Clinical Excellence (NICE) Backs Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE)'s Eliquis More... •  Pfizer Inc. (PFE) Lipitor Plan Might Not Be "Worth It," Watson Pharmaceuticals, Inc. (WPI) CEO Says More... •  Merck & Co., Inc. (MRK)'s Cholesterol Drug Vytorin to Get New Label More... More Drug Product News Hot Company Novo Nordisk 530 Fairview Avenue North Seattle, Washington 98109 U.S.A. Phone: 206-490-5700 Novo Nordisk is the world's leading diabetes care company and the only company that provides a complete portfolio of insulin analog treatments and insulin delivery devices that respond to each stage of the diabetes life cycle. More Company Profiles Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship ClinicaSpace 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 ClinicaSpace 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the ClinicaSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong ClinicaSpace.com - Clinical Trials. Clinical Research. Community. • ClinicaSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 ClinicaSpace http://www.clinicaspace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.